Genocea Biosciences, Inc (GNCA) Covered Calls

You can sell covered calls on Genocea Biosciences, Inc to lower risk and earn monthly income. Born To Sell's covered call screener gives you customized search capabilities across all possible covered calls but here are a couple of examples for GNCA (prices last updated Fri 4:16 PM ET):

Genocea Biosciences, Inc (GNCA) Stock Quote
Last Change Bid Ask Volume P/E Market Cap
0.58 -0.04 0.54 0.64 43K - 0.0B
Covered Calls For Genocea Biosciences, Inc (GNCA)
Expiration Strike Call Bid Net Debit Return
If Flat		 Annualized
Return If Flat
Dec 21 2.5 0.00 0.64 0.0% 0.0%
Jan 18 2.5 0.00 0.64 0.0% 0.0%
Subscribers get access to the full covered call chain, and more features.

Want to make money with covered calls?  Sign Up For A Free Trial

Extended Business Description

Genocea Biosciences, Inc., a biopharmaceutical company, discovers and develops novel cancer vaccines. The company uses its proprietary discovery platform AnTigen Lead Acquisition System to design immunotherapies and vaccines that act through T cell immune responses. Its lead product candidate is GEN-003, an investigational immunotherapy that is in Phase III trial for the treatment of genital herpes infections. The company is also develops GEN-009, which is in pre-clinical stage to treat neoantigen cancer; GEN-010 that is in pre-clinical stage for the treatment of patients in second generation neoantigen cancer; GEN-007, which is in research stage to Epstein-Barr virus; and GEN-006 that is in research stage for the treatment of immune-oncology-tumor-associated antigen cancer. It license agreement with University of California and Harvard University; and collaboration agreement with Novavax, Inc. Genocea Biosciences, Inc. was founded in 2006 and is headquartered in Cambridge, Massachusetts.